Director Declaration

RNS Number : 1254L

Phoenix Group Holdings

23 April 2015

 



Phoenix Group Holdings (the "Company")

In compliance with Listing Rule 9.6.14, the Company announces that with effect from 21 April 2015, Rene-Pierre Azria, a non-executive director of the Company, has been appointed a director of Immune Pharmaceuticals Inc, whose shares are listed in the USA on the NASDAQ.

Enquiries:

Media Neil Bennett, Maitland Peter Ogden, Maitland + 44 (0) 20 7379 5151

Investors Sam Perowne, Head of Investor Relations, Phoenix Group [phone]

 

END

 

 

RDNKMGZDGFZGKZM